ONCOR B/T GENE REARRANGEMENT TEST

Dna-probe, B And T Lymphocyte

FDA Premarket Approval P880016 S002

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

DeviceONCOR B/T GENE REARRANGEMENT TEST
Classification NameDna-probe, B And T Lymphocyte
Generic NameDna-probe, B And T Lymphocyte
ApplicantONCOR, INC.
Date Received1990-04-10
Decision Date1990-04-24
PMAP880016
SupplementS002
Product CodeMAM
Advisory CommitteeHematology
Supplement TypeNormal 180 Day Track
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product No
Applicant Address ONCOR, INC. 209 Perry Pkwy. gaithersburg, MD 20877

Supplemental Filings

Supplement NumberDateSupplement Type
P880016Original Filing
S004 1992-08-26 Normal 180 Day Track
S003 1991-06-07 Normal 180 Day Track
S002 1990-04-10 Normal 180 Day Track
S001 1989-12-18 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.